Treatment of Alzheimer's disease with inhibitors of APoE binding to APoE receptor

Details for Australian Patent Application No. 2007217039 (hide)

Owner Oklahoma Medical Research Foundation

Inventors Tang, Jordan

Agent Pizzeys

Pub. Number AU-A-2007217039

PCT Pub. Number WO2007/098417

Priority 60/775,477 21.02.06 US

Filing date 16 February 2007

Wipo publication date 30 August 2007

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/098417 Priority application(s): WO2007/098417

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217040-Compounds having 5-HT6 receptor affinity

2007217037-Peptide based inhibition of caPCNA protein-protein interactions in cancer